Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications (Q38245668)

31 August 2017

title

Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications (English)

1 reference

31 August 2017

4

Jakub Fichna

1 reference

31 August 2017

Chunqiu Chen

1

1 reference

31 August 2017

Zhen Yu

series ordinal

2

1 reference

31 August 2017

Yongyu Li

series ordinal

3

1 reference

31 August 2017

Martin Storr

series ordinal

5

1 reference

31 August 2017

language of work or name

1 reference

3 September 2014

1 reference

The American Journal of Chinese Medicine

31 August 2017

published in

1 reference

31 August 2017

volume

42

1 reference

31 August 2017

issue

5

1 reference

31 August 2017

page(s)

1053-1070

1 reference

TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Upregulating reverse cholesterol transport with cholesteryl ester transfer protein inhibition requires combination with the LDL-lowering drug berberine in dyslipidemic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Antimicrobial activity of berberine--a constituent of Mahonia aquifolium

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Effects of berberine on rat jejunal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

The role of Coptidis Rhizoma extract in a renal ischemia-reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine acutely activates the glucose transport activity of GLUT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Therapeutic strategies based on glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Anti-hyperglycemic effects and mechanism of traditional Chinese medicine Huanglian Wan in streptozocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Mechanisms of action of glucagon-like peptide 1 in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARγ pathway during acute endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine reduces rat intestinal tight junction injury induced by ischemia-reperfusion associated with the suppression of inducible nitric oxide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine ameliorates pro-inflammatory cytokine-induced endoplasmic reticulum stress in human intestinal epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Sensing of energy and nutrients by AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Chinese herbal medicinal ingredients inhibit secretion of IL-6, IL-8, E-selectin and TXB2 in LPS-induced rat intestinal microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine suppresses proinflammatory responses through AMPK activation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Eucommiae cortex inhibits TNF-α and IL-6 through the suppression of caspase-1 in lipopolysaccharide-stimulated mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Moringa fruit inhibits LPS-induced NO/iNOS expression through suppressing the NF-κ B activation in RAW264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine alkaloid as a sensitive fluorescent probe for bile salt aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

The involvement of P-glycoprotein in berberine absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Expression and function of efflux drug transporters in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine hydrochloride: anticancer activity and nanoparticulate delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Antinociceptive effect of berberine on visceral hypersensitivity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine inhibits ion transport in human colonic epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine: new perspectives for old remedies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Orengedokuto and berberine improve indomethacin-induced small intestinal injury via adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Palmatine, a protoberberine alkaloid, inhibits both Ca(2+)- and cAMP-activated Cl(-) secretion in isolated rat distal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Efficacy of berberine in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Effect of jatrorrhizine on delayed gastrointestinal transit in rat postoperative ileus

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

Increased systemic exposure to rhizoma coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X14500669

10.1142/S0192415X14500669

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference